173 related articles for article (PubMed ID: 31422386)
1. Utilization of Mesenchymal Stem Cells in Kidney Transplantation: From Bench to Bedside.
Saidi RF; Moghadasali R; Shekarchian S
Iran J Kidney Dis; 2019 Jul; 13(4):213-224. PubMed ID: 31422386
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stromal cells in renal transplantation: opportunities and challenges.
Casiraghi F; Perico N; Cortinovis M; Remuzzi G
Nat Rev Nephrol; 2016 Apr; 12(4):241-53. PubMed ID: 26853275
[TBL] [Abstract][Full Text] [Related]
3. Effect of Timing and Complement Receptor Antagonism on Intragraft Recruitment and Protolerogenic Effects of Mesenchymal Stromal Cells in Murine Kidney Transplantation.
Casiraghi F; Todeschini M; Azzollini N; Cravedi P; Cassis P; Solini S; Fiori S; Rota C; Karachi A; Carrara C; Noris M; Perico N; Remuzzi G
Transplantation; 2019 Jun; 103(6):1121-1130. PubMed ID: 30801518
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Bone Marrow-Derived Mesenchymal Stem Cells for Chronic Antibody-Mediated Rejection After Kidney Transplantation- A Single-Arm, Two-Dosing-Regimen, Phase I/II Study.
Wei Y; Chen X; Zhang H; Su Q; Peng Y; Fu Q; Li J; Gao Y; Li X; Yang S; Ye Q; Huang H; Deng R; Li G; Xu B; Wu C; Wang J; Zhang X; Su X; Liu L; Xiang AP; Wang C
Front Immunol; 2021; 12():662441. PubMed ID: 34248942
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic mesenchymal stem cell as induction therapy to prevent both delayed graft function and acute rejection in deceased donor renal transplantation: study protocol for a randomized controlled trial.
Sun Q; Hong L; Huang Z; Na N; Hua X; Peng Y; Zhao M; Cao R; Sun Q
Trials; 2017 Nov; 18(1):545. PubMed ID: 29145879
[TBL] [Abstract][Full Text] [Related]
6. Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study.
Erpicum P; Weekers L; Detry O; Bonvoisin C; Delbouille MH; Grégoire C; Baudoux E; Briquet A; Lechanteur C; Maggipinto G; Somja J; Pottel H; Baron F; Jouret F; Beguin Y
Kidney Int; 2019 Mar; 95(3):693-707. PubMed ID: 30528263
[TBL] [Abstract][Full Text] [Related]
7. Marrow Mesenchymal Stem Cells Effectively Reduce Histologic Changes in a Rat Model of Chronic Renal Allograft Rejection.
Yu P; Wang Z; Liu Y; Xiao Z; Guo Y; Li M; Zhao M
Transplant Proc; 2017 Nov; 49(9):2194-2203. PubMed ID: 29149982
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial.
Sun Q; Huang Z; Han F; Zhao M; Cao R; Zhao D; Hong L; Na N; Li H; Miao B; Hu J; Meng F; Peng Y; Sun Q
J Transl Med; 2018 Mar; 16(1):52. PubMed ID: 29514693
[TBL] [Abstract][Full Text] [Related]
9. Challenges in allogeneic mesenchymal stem cell-mediated cardiac repair.
Dhingra S; Huang XP; Li RK
Trends Cardiovasc Med; 2010 Nov; 20(8):263-8. PubMed ID: 22433652
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem-cell immunosuppressive capabilities: therapeutic implications in islet transplantation.
Ding Y; Bushell A; Wood KJ
Transplantation; 2010 Feb; 89(3):270-3. PubMed ID: 20145515
[TBL] [Abstract][Full Text] [Related]
11. Clinical translation of multipotent mesenchymal stromal cells in transplantation.
Leuning DG; Reinders ME; de Fijter JW; Rabelink TJ
Semin Nephrol; 2014 Jul; 34(4):351-64. PubMed ID: 25217264
[TBL] [Abstract][Full Text] [Related]
12. Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation.
Comoli P; Ginevri F; Maccario R; Avanzini MA; Marconi M; Groff A; Cometa A; Cioni M; Porretti L; Barberi W; Frassoni F; Locatelli F
Nephrol Dial Transplant; 2008 Apr; 23(4):1196-202. PubMed ID: 18029377
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory effects of mesenchymal stem cells derived from adipose tissues in a rat orthotopic liver transplantation model.
Wan CD; Cheng R; Wang HB; Liu T
Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):29-33. PubMed ID: 18234635
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory effects of mesenchymal stem cells for the treatment of cardiac allograft rejection.
Wu Z; Liang J; Huang W; Jiang L; Paul C; Gao X; Alam P; Kanisicak O; Xu M; Wang Y
Exp Biol Med (Maywood); 2021 Apr; 246(7):851-860. PubMed ID: 33327780
[TBL] [Abstract][Full Text] [Related]
16. Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?
Griffin MD; Ryan AE; Alagesan S; Lohan P; Treacy O; Ritter T
Immunol Cell Biol; 2013 Jan; 91(1):40-51. PubMed ID: 23207278
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stromal cells as a means of controlling pathological T-cell responses in allogeneic islet transplantation.
Reading JL; Sabbah S; Busch S; Tree TI
Curr Opin Organ Transplant; 2013 Feb; 18(1):59-64. PubMed ID: 23222174
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stromal cells in transplantation rejection and tolerance.
English K; Wood KJ
Cold Spring Harb Perspect Med; 2013 May; 3(5):a015560. PubMed ID: 23637312
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow-derived mesenchymal stem cells as immunosuppressants in liver transplantation: a review of current data.
Zhang H; Chen Z; Bie P
Transfus Med Rev; 2012 Apr; 26(2):129-41. PubMed ID: 22015073
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cardiac allograft rejection in mice using interleukin-35-modified mesenchymal stem cells.
Wang W; Zhao N; Li B; Gao H; Yan Y; Guo H
Scand J Immunol; 2019 Apr; 89(4):e12750. PubMed ID: 30664805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
